Vinge has assisted Vostok New Ventures Ltd (“Vostok”) in connection with an investment by a number of investors of in total USD 85 million in Voi Technology AB, a company that provides an electric scooter sharing service.
On 7 November 2019, Vonovia SE announced, through its indirectly wholly-owned subsidiary HomeStar InvestCo AB, a mandatory cash offer to the shareholders of Hembla AB (publ) to acquire all shares in Hembla.
Samhällsbyggnadsbolaget i Norden AB (publ) (“SBB”) has announced a recommended public offer to the shareholders of Hemfosa Fastigheter AB (publ) (“Hemfosa”) to tender all their shares in Hemfosa to SBB.
Vinge has advised Skandinaviska Enskilda Banken AB (publ) as to Swedish law in connection with the issuance of Additional Tier 1 Capital (AT1) of USD 900 million to optimise its capital structure.
Vinge has advised Vicore Pharma, a Swedish rare disease company focused on interstitial lung diseases and related indications, in connection with a directed share issue whereby Vicore Pharma will receive approximately SEK 125 million in issue proceeds.
Vinge has advised the hotel property owner Pandox in connection with a directed share issue of 16,350,000 class B shares, whereby Pandox will receive approximately SEK 3 billion in issue proceeds.
Vinge has assisted with counselling on securities law and transaction execution in connection with Samhällsbyggnadsbolaget i Norden AB (publ)’s list change of their B‑ and D‑shares from Nasdaq First North Premier Growth Market to Nasdaq Stockholm’s main market.
Vinge has advised EQT AB (publ) (“EQT”) in connection with the offering and listing on Nasdaq Stockholm with first day of trading on 24 September 2019.
Vinge advises Vicore Pharma Holding AB (publ) in connection with its list change from Nasdaq First North Growth Market to Nasdaq Stockholm’s main market.
